Sheagh S.A.
Records under this name other than patents Sheagh S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Sheagh S.A.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,248,552 | Enzyme-based assay for determining effects of exogenous and endogenous factors on cellular energy production Term ended Term ended Oct 24, 2017 · From the USPTO record | Term ended | Term ended Oct 24, 2017 | From the USPTO record |
| US 6,383,771 | Enzyme-based assay for determining effects of exogenous and endogenous factors on cellular energy Lapsed on the fee record Ended May 7, 2014 · From the USPTO record | Lapsed on the fee record | Ended May 7, 2014 | From the USPTO record |
| US 5,332,727 | Stable, ingestable and absorbable NADH and NADPH therapeutic compositions Term ended Term ended no later than Jul 26, 2014 · Low confidence | Term ended | Term ended no later than Jul 26, 2014 | Low confidence |
| US 5,444,053 | Method for treating symptoms of Alzheimer's with NADH and NADPH Term ended Term ended no later than Aug 22, 2015 · Low confidence | Term ended | Term ended no later than Aug 22, 2015 | Low confidence |
| US 5,654,288 | Stable NADH and NADPH compositions for sublingual administration Term ended Term ended no later than Aug 5, 2017 · Low confidence | Term ended | Term ended no later than Aug 5, 2017 | Low confidence |
| US 5,668,114 | NADH and NADPH pharmaceuticals for treating hypertension Term ended Term ended no later than Sep 16, 2017 · Low confidence | Term ended | Term ended no later than Sep 16, 2017 | Low confidence |
| US 5,712,259 | NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome Term ended Term ended no later than Jan 27, 2018 · Low confidence | Term ended | Term ended no later than Jan 27, 2018 | Low confidence |
| US 5,750,512 | NADH and NADPH therapeutic agents for nasal, sublingual, rectal and dermal administration Term ended Term ended no later than May 12, 2018 · Low confidence | Term ended | Term ended no later than May 12, 2018 | Low confidence |
| US 5,952,312 | NADH and NADPH therapeutic agents for nasal, sublingual, rectal and dermal administration Term ended Term ended no later than Sep 14, 2019 · Low confidence | Term ended | Term ended no later than Sep 14, 2019 | Low confidence |